Claritev (CTEV) EBITDA (2019 - 2026)

Claritev's EBITDA history runs 8 years deep, the most recent figure standing at $6.6 million for Q1 2026.

• On a quarterly basis, EBITDA fell 31.85% year-over-year to $6.6 million in Q1 2026; TTM through Mar 2026 was $25.7 million, a 102.87% increase from a year earlier, with the FY2025 full-year figure at $28.8 million, up 102.07% from the prior year.
• EBITDA rose to $6.6 million in Q1 2026 per CTEV's latest filing, from -$7.6 million in the prior quarter.
• Across five years, EBITDA topped out at $116.6 million in Q1 2022 and bottomed at -$613.5 million in Q4 2022.
• The 5-year median for EBITDA is $10.1 million (2025), against an average of -$91.5 million.
• Across the five-year window, EBITDA surged 106.65% in 2023 and slumped 1609.57% in 2024, its largest moves.
• Year by year, EBITDA stood at -$613.5 million in 2022, then surged by 106.65% to $40.8 million in 2023, then plunged by 201.34% to -$41.4 million in 2024, then soared by 81.57% to -$7.6 million in 2025, then jumped by 187.1% to $6.6 million in 2026.
• Per Business Quant, the three latest CTEV EBITDA figures stand at $6.6 million (Q1 2026), -$7.6 million (Q4 2025), and $10.1 million (Q3 2025).